Noho Labs develops personalized peptide therapies and was co-founded by Matt Mazzeo, formerly a general partner at Coatue. The company is pursuing tailored peptide solutions and is positioning itself to scale R&D efforts following its recent financing. After raising $16 million, Noho Labs plans to intensify research and development and accelerate product commercialization. Coverage highlights a potentially favorable U.S. regulatory backdrop for peptides under Health Secretary Robert F. Kennedy Jr., which the company and investors cited as supportive context. Aside from the $16 million raise and its leadership team, the articles did not report specific revenue, user metrics, or prior funding rounds.

Total raised

$16M

Funding rounds

1

Latest round

Equity

Latest activity

May 2026